Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectives.
Yilmaz, Musa; Kantarjian, Hagop; Ravandi-Kashani, Farhad; Short, Nicholas J; Jabbour, Elias.
Clin Adv Hematol Oncol
; 16(3): 216-223, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29742077
Treatment of Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia.
CD19 CAR T Cells.
Acute lymphoblastic leukemia: pathophysiology and current therapy.
Acute lymphoblastic leukemia in adolescents and young adults: from the viewpoint of pediatricians.
Time to tune the treatment of Ph+ ALL.
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.
NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017.
[Acute lymphoblastic leukemia/ lymphoblastic lymphoma: ALL/LBL].
The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.